Renal Amyloidosis: Presentation, Diagnosis, and Management

Area of Science:

• Nephrology
• Pathology
• Internal Medicine

Background:

• Over 35 amyloid precursor proteins are known, with many affecting the kidneys.
• Renal amyloidosis commonly manifests as AL and AA amyloidosis.
• Key clinical signs include proteinuria and worsening kidney function.

Purpose of the Study:

• To summarize the pathology and management of renal amyloidosis.
• To highlight diagnostic features and treatment strategies.

Main Methods:

• Review of renal pathology findings, including Congo red staining and electron microscopy.
• Analysis of clinical manifestations and disease progression.
• Overview of current management approaches.

Main Results:

• Amyloidosis in kidneys shows Congo red positivity with apple-green birefringence.
• Electron microscopy reveals randomly arranged fibrils (7-12 nm).
• Proteinuria and progressive renal dysfunction are primary clinical outcomes.

Conclusions:

• Renal amyloidosis requires management targeting the underlying disease and supportive care.
• Dialysis and renal transplantation are options for end-stage renal disease in amyloidosis patients.